뉴캐슬병바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액
    2.
    发明公开
    뉴캐슬병바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액 有权
    新陈代谢病毒HN蛋白和含有其的新鲜病毒的诊断组合物

    公开(公告)号:KR1020130071693A

    公开(公告)日:2013-07-01

    申请号:KR1020110139057

    申请日:2011-12-21

    Abstract: PURPOSE: An HN protein of Newcastle disease virus (NDV) and an NDV antigen diagnostic liquid containing the same for a hemagglutination inhibition (HI) method are provided to quickly and cheaply produce the NDV antigen diagnostic liquid without contamination or disease infection. CONSTITUTION: A method for preparing a recombinant baculovirus expression vector comprises the steps of: isolating virus genome RNA from NDV Lasota strain; synthesizing cDNA of HN protein of NDV protein using a reverse primer of sequence number 2 and RNA; performing PCR of cDNA using a forward primer of sequence number 1, and a reverse primer of sequence number 2 to synthesize DNA; treating the synthesized DNA with Xba1 and Hind III, and extracting DNA fragments; and inserting the DNA fragment into a multicloning site of pFastBac TM 1 expression vector with baculovirus polyhedron promoter. [Reference numerals] (AA) Novel method; (BB) Conventional method; (CC) Normal cells

    Abstract translation: 目的:提供新城疫病毒(NDV)的HN蛋白和含有血细胞凝集抑制(HI)方法的NDV抗原诊断液,以快速,便宜地生产无污染或疾病感染的NDV抗原诊断液。 构成:制备重组杆状病毒表达载体的方法包括以下步骤:从NDV Lasota菌株中分离病毒基因组RNA; 使用序列号2和RNA的反向引物合成NDV蛋白的HN蛋白的cDNA; 使用序列号1的正向引物进行cDNA的PCR和序列号2的反向引物合成DNA; 用Xba1和Hind III处理合成的DNA,提取DNA片段; 并将DNA片段插入具有杆状病毒多面体启动子的pFastBac TM 1表达载体的多克隆位点。 (附图标记)(AA)新方法; (BB)常规方法; (CC)正常细胞

    제4형 조류파라믹소바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액
    4.
    发明授权
    제4형 조류파라믹소바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액 有权
    HN蛋白的AVIAN PARAMYXOVIRUS-4和诊断组合物对于含有其的PARAMYXOVIRUS-4

    公开(公告)号:KR101374192B1

    公开(公告)日:2014-03-14

    申请号:KR1020110139058

    申请日:2011-12-21

    Abstract: 본 발명은 제4형 조류파라믹소바이러스(avian paramyxovirus-4, APMV-4)의 진단에 관한 것이다
    상기와 같은 본 발명에 따르면, 제4형 조류파라믹소바이러스(avian paramyxovirus-4, APMV-4) HN(haemagglutinin-neuraminidase) 유전자를 포함하는 재조합 베큘로바이러스 발현벡터를 곤충세포에 형질감염시키고, 상기 곤충세포에서 발현된 APMV-4 HN 단백질 및 이를 포함하는 혈구응집억제시험법(hemagglutination inhibition, HI법) 검사용 NDV 항원진단액과 상기 NDV 항원진단액을 이용한 혈구응집억제시험법(hemagglutination inhibition, HI법) 검사용 APMV-4 항체진단액을 제공함으로서, 살아있는 APMV-4를 취급하는 과정에서 발생할 수 있는 주변 오염이나 질병 전염의 위험성을 배제할 뿐만 아니라 신속하고 경제적인 방법으로 APMV-4 항원 및 항체진단액을 대량생산할 수 있는 효과가 있다.

    제4형 조류파라믹소바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액
    5.
    发明公开
    제4형 조류파라믹소바이러스 HN 단백질 및 이를 포함하는 HI법 검사용 항원진단액 有权
    HN蛋白的AVIAN PARAMYXOVIRUS-4和诊断组合物对于含有其的PARAMYXOVIRUS-4

    公开(公告)号:KR1020130085557A

    公开(公告)日:2013-07-30

    申请号:KR1020110139058

    申请日:2011-12-21

    Abstract: PURPOSE: HN protein of avian paramyxovirus-4 (APMV-4) and an antigen diagnostic solution for HI method examination including the same are provided to be able to exclude the danger of neighbor contamination or disease contagion in the process of treating live APMV-4, and to be able to mass-produce the APMV-4 antigen and antibody diagnostic solution in a rapid and economic method. CONSTITUTION: A manufacturing method of an expression vector of recombinant baculovirus including HN gene of APMV-4 comprises (1) a step of extracting virus genome RNA from APMV-4 La Sota strain; (2) a step of synthesizing cDNA of HN protein gene of APMV-4 by using the extracted RNA and reverse primer of Sequence 2; (3) a step of amplifying the synthesized cDNA, forward primer of Sequence 1, and reverse primer of Sequence 2 by using PCR, and synthesizing DNA; (4) a step of extracting DNA fragment by treating the synthesized DNA with EcoR1 and Hind III; and (5) a step of inserting the extracted DNA fragment into the multicloning site of pFastBac^TM1 expression vector having baculovirus polyhedrin promoter (PPH). The forward primer of Sequence 1 is that EcoR1 restriction enzyme acting site is inserted into the upper part of ATG of 5' end terminal. The revers primer of Sequence 2 is that Hind III restriction enzyme acting site is inserted into the upper part of end codon of 5' end terminal.

    Abstract translation: 目的:提供禽副粘病毒-4(APMV-4)的HN蛋白和包括其中的HI方法检测的抗原诊断溶液,以能够排除在治疗APMV-4过程中相邻污染或疾病传染的危险 并能够以快速,经济的方式大量生产APMV-4抗原和抗体诊断溶液。 构成:APMV​​-4的HN基因重组杆状病毒表达载体的制造方法包括:(1)从APMV-4 La Sota菌株中提取病毒基因组RNA的步骤; (2)使用提取的RNA和序列2的反向引物合成APMV-4的HN蛋白基因的cDNA的步骤; (3)使用PCR扩增合成的cDNA,序列1的正向引物和序列2的反向引物的步骤,合成DNA; (4)通过用EcoRⅠ和HindⅢ处理合成的DNA来提取DNA片段的步骤; (5)将提取的DNA片段插入具有杆状病毒多角体蛋白启动子(PPH)的pFastBac TM TM1表达载体的多克隆位点的步骤。 序列1的正向引物是EcoR1限制酶作用位点插入5'端末端ATG的上部。 序列2的反向引物是HindIII限制酶作用位点插入5'末端末端密码子的上部。

    국내사육 닭에서 유행하는 신규한 B형 조류메타뉴모바이러스 SC1509주 및 이의 용도
    6.
    发明公开
    국내사육 닭에서 유행하는 신규한 B형 조류메타뉴모바이러스 SC1509주 및 이의 용도 有权
    在韩国从鸡分离的禽类间质肺炎病毒B型SC1509菌株及其用途

    公开(公告)号:KR1020110045648A

    公开(公告)日:2011-05-04

    申请号:KR1020090102305

    申请日:2009-10-27

    Abstract: PURPOSE: A vaccine containing avian metapneumovirus SC1509 strain for preventing avian metapneumovirus infection is provided to ensure efficiency against severe virus. CONSTITUTION: An avian metapneumovirus SC1509 strain is deposited in the number of KCTC 11576BP. The virus has a nucleic acid sequence of sequence number 5 and G protein encoded by nucleic acid sequence of sequence number 6. A vaccine is alive vaccine containing the avian metapneumovirus SC1509 strain. The vaccine is inactivated vaccine, sub-unit vaccine, vector vaccine, chimera vaccine, or DNA vaccine. The vaccine further contains an adjuvant as an excipient.

    Abstract translation: 目的:提供含有用于预防禽类间质肺病毒感染的禽类偏肺病毒SC1509菌株的疫苗,以确保针对严重病毒的效力。 构成:禽类间断肺病毒SC1509菌株以KCTC 11576BP的数量沉积。 病毒具有序列号5的核酸序列和由序列号6的核酸序列编码的G蛋白。疫苗是含有禽偏肺病毒SC1509菌株的活的疫苗。 疫苗是灭活疫苗,亚单位疫苗,载体疫苗,嵌合疫苗或DNA疫苗。 疫苗还含有佐剂作为赋形剂。

Patent Agency Ranking